XML 60 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Sep. 29, 2012
Oct. 01, 2011
Cash Flows from Operating Activities:    
Net income $ 16,335 $ 30,828
Non cash items:    
Depreciation and amortization 28,610 24,619
Stock compensation expense 5,014 4,701
Loss on sales of property, plant and equipment 218 278
Unrealized loss from hedging activities 166 1,080
Contingent consideration income 0 (1,580)
Reversal of interest expense on contingent consideration 0 (574)
Deferred tax 460 0
Change in operating assets and liabilities:    
Increase in accounts receivable, net (22,686) (1,332)
Increase in inventories (3,448) (15,390)
Decrease in prepaid income taxes (2,197) 12,283
Increase in other assets and other long-term liabilities (4,337) (1,267)
Tax benefit on exercise of stock options 2,488 952
Decrease in accounts payable and accrued expenses 12,944 (2,059)
Net cash provided by operating activities 33,567 52,539
Cash Flows from Investing Activities:    
Capital expenditures on property, plant and equipment (34,432) (23,843)
Proceeds from sale of property, plant and equipment 355 130
Acquisition of ACCS (535,144) 0
Acquisition of Global Med Technologies (1,000) 0
Net cash used in investing activities (570,221) (23,713)
Cash Flows from Financing Activities:    
Payments on long-term real estate mortgage (434) (634)
Net increase/(decrease) in short-term loans 3,217 1,992
Term loan 475,000 0
Debt issuance costs (5,462) 0
Proceeds from employee stock purchase plan 2,105 1,847
Proceeds from exercise of stock options 23,649 4,707
Excess tax benefit on exercise of stock options 2,079 333
Share repurchase (5,342) (49,998)
Net cash used in financing activities 494,812 (41,753)
Effect of exchange rates on cash and cash equivalents 32 (359)
Net increase in Cash and Cash Equivalents (41,810) (13,286)
Cash and Cash Equivalents at Beginning of Year 228,861 196,707
Cash and Cash Equivalents at End of Period 187,051 183,421
Non-cash Investing and Financing Activities:    
Transfers from inventory to fixed assets for placements of Haemonetics equipment 11,167 6,292
Supplemental Disclosures of Cash Flow Information:    
Interest paid 1,688 220
Income taxes paid $ 7,338 $ 2,288